New line will turn out to be core manufacturing base for 5G·HPC·AI options with 5nm EUV
Samsung started development this month for quantity manufacturing in 2H 2021
Samsung Electronics, a world chief in superior semiconductor know-how, in the present day introduced plans to spice up its foundry capability on the firm’s new manufacturing line in Pyeongtaek, Korea, to satisfy rising world demand for cutting-edge excessive ultraviolet (EUV) options.
The new foundry line, which is able to give attention to EUV-based 5 nanometer (nm) and under course of know-how, has simply commenced development this month and is anticipated to be in full operation within the second half of 2021. It will play a pivotal position as Samsung goals to increase using state-of-the-art course of applied sciences throughout a myriad of present and subsequent technology purposes, together with 5G, high-performance computing (HPC) and synthetic intelligence (AI).
“This new production facility will expand Samsung’s manufacturing capabilities for sub-5nm process and enable us to rapidly respond to the increasing demand for EUV-based solutions,” mentioned Dr. ES Jung, President and Head of Foundry Business at Samsung Electronics. “We remain committed to addressing the needs of our customers through active investments and recruitment of talents. This will enable us to continue to break new ground while driving robust growth for Samsung’s foundry business.”
Following the preliminary mass manufacturing of the EUV-based 7nm course of in early 2019, Samsung not too long ago added a brand new EUV-dedicated V1 line in Hwaseong, Korea, to its world foundry community. With the brand new Pyeongtaek facility beginning full operation in 2021, Samsung’s foundry capability primarily based on EUV is anticipated to extend considerably.
Samsung is scheduled to start out mass manufacturing of 5nm EUV course of within the Hwaseong fab within the second half of this 12 months.
With the addition of the Pyeongtaek fab, Samsung may have a complete of seven foundry manufacturing strains positioned in South Korea and the United States, comprised of six 12-inch strains and one 8-inch line.
